Cancer Diagnostics Industry Data Book - Breast Cancer Diagnostic, Cervical Cancer Diagnostic, Lung Cancer Diagnostic, Liver Cancer Diagnostic, Pancreatic Cancer Diagnostic and Ovarian Cancer Diagnostic Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

Published Date: Jul, 2023
Report ID: sector-report-00180
Format: Electronic (PDF)
Number of Pages: 350

Chapter 1 Methodology and Scope

1.1 Market Segmentation
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using the bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1
1.11.2 Objective 2
1.12 List Of Abbreviations

Chapter 2 Market Definitions

2.1 Definitions

Chapter 3 Executive Summary

3.1 Market Summary

Chapter 4 Cancer Diagnostics Market Variables, Trends, & Scope

4.1 Cancer Diagnostics Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration And Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rising Prevalence Of Cancer
4.4.2 Technological Advancements
4.4.4 Rising Initiatives Undertaken By Public And Private Organizations
4.5 Market Restraint Analysis
4.5.1 High Cost Of Diagnostic Imaging
4.5.2 Radiation Exposure Likely To Limit Usage Of Ct Scans
4.6 Breast Cancer Diagnostic Market Analysis Tools
4.6.1 Industry Analysis - Porter’s
4.6.2 SWOT Analysis, By PEST
4.7 Cervical Cancer Diagnostic Market Analysis Tools
4.7.1 Industry Analysis - Porter’s
4.7.2 SWOT Analysis, By PEST
4.8 Lungs Cancer Diagnostic Market Analysis Tools
4.8.1 Industry Analysis - Porter’s
4.8.2 SWOT Analysis, By PEST
4.9 Liver Cancer Diagnostic Market Analysis Tools
4.9.1 Industry Analysis - Porter’s
4.9.2 SWOT Analysis, By PEST
4.10 Pancreatic Cancer Diagnostic Market Analysis Tools
4.10.1 Industry Analysis - Porter’s
4.10.2 SWOT Analysis, By PEST
4.11 Ovarian Cancer Diagnostic Market Analysis Tools
4.11.1 Industry Analysis - Porter’s
4.11.2 SWOT Analysis, By PEST

Chapter 5 Cancer Diagnostics Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

5.1 Global Cancer Diagnostics Market: Application Movement Analysis
5.2 Breast Cancer
5.2.1 Breast Cancer Market Estimates And Forecast, 2018 - 2030 (USD)
5.3 Cervical Cancer
5.3.1 Cervical Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Lung Cancer
5.4.1 Lung Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.5 Liver Cancer
5.5.1 Liver Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Pancreatic Cancer
5.6.1 Pancreatic Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Ovarian Cancer
5.7.1 Ovarian Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Breast Cancer Diagnostics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

6.1 Breast Cancer Diagnostics Market: Type Analysis
6.2 Imaging
6.2.1 Imaging Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.3 Biopsy
6.3.1 Biopsy Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.4 Genomic Tests
6.4.1 Genomic Tests Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.5 Blood Tests
6.5.1 Blood Tests Market Estimates and Forecast, 2018 - 2030 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Cervical Cancer Diagnostics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

7.1 Cervical Cancer Diagnostics Market: Type Movement Analysis
7.2 Pap testing (Cytology testing)
7.2.1 Pap testing (Cytology testing) Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 HPV Testing
7.3.1 HPV Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Colposcopy
7.4.1 Colposcopy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Cervical Biopsies
7.5.1 Cervical Biopsies Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Cystoscopy
7.6.1 Cystoscopy Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Lung Cancer Diagnostics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

8.1 Lung Cancer Diagnostics Market: Type Movement Analysis
8.2 Imaging
8.2.1 Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Sputum Cytology
8.3.1 Sputum Cytology Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Biopsy
8.4.1 Biopsy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Others
8.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Liver Cancer Diagnostics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

9.1 Liver Cancer Diagnostics Market: Type Movement Analysis
9.2 Imaging
9.2.1 Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.3 Laboratory Tests
9.3.1 Laboratory Tests Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.4 Biopsy
9.4.1 Biopsy Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.5 Others
9.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 10 Pancreatic Cancer Diagnostics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

10.1 Pancreatic Cancer Diagnostics Market: Type Movement Analysis
10.2 Imaging
10.2.1 Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3 Blood Test
10.3.1 Blood Test Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4 Biopsy
10.4.1 Biopsy Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5 Others
10.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 11 Ovarian Cancer Diagnostics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

11.1 Ovarian Cancer Diagnostics Market: Type Movement Analysis
11.2 Imaging
11.2.1 Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)
11.3 Blood Test
11.3.1 Blood Test Market Estimates And Forecast, 2018 - 2030 (USD Million)
11.4 Biopsy
11.4.1 Biopsy Market Estimates And Forecast, 2018 - 2030 (USD Million)
11.5 Others
11.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 12 Cancer Diagnostics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

12.1 Cancer Diagnostics Market: Type Movement Analysis
12.2 IVD
12.2.1 IVD Market Estimates And Forecast, 2018 - 2030 (USD Million)
12.3 LDT
12.3.1 LDT Market Estimates And Forecast, 2018 - 2030 (USD Million)
12.4 Imaging
12.4.1 Imaging Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 13 Cancer Diagnostics Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

13.1 Cancer Diagnostics Market: End-use Movement Analysis
13.2 Hospitals
13.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.3 Laboratories
13.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
13.4 Others
13.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 14 Cancer Diagnostics Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

14.1 Cancer Diagnostics Market: Regional Movement Analysis
14.2 North America
14.2.1 North America, SWOT Analysis
14.2.2 North America Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.2.3 U.S.
14.2.3.1 U.S. Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.2.4 Canada
14.2.4.1 Canada Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3 Europe
14.3.1 Europe, SWOT Analysis
14.3.2 Europe Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.3 UK
14.3.3..1 UK Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.4 Germany
14.3.4.1 Germany Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.5 Spain
14.3.5.1 Spain Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.6 France
14.3.6.1 France Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.7 Italy
14.3.7.1 Italy Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.8 Denmark
14.3.8.1 Denmark Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.9 Sweden
14.3.9.1 Sweden Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.3.10 Norway
14.3.10.1 Norway Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.4 Asia Pacific
14.4.1 Asia Pacific, SWOT Analysis
14.4.2 Asia Pacific Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.4.3 Japan
14.4.3.1 Japan Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.4.4 China
14.4.4.1 China Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.4.5 India
14.4.5.1 India Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.4.6 South Korea
14.4.6.1 South Korea Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.4.7 Thailand
14.4.7.1 Thailand Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.4.8 Australia
14.4.8.1 Australia Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.5 Latin America
14.5.1 Latin America, SWOT Analysis
14.5.2 Latin America Market Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.5.3 Brazil
14.5.3.1 Brazil Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.5.4 Mexico
14.5.4.1 Mexico Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.5.5 Argentina
14.5.5.1 Argentina Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.6 Middle East and Africa
14.6.1 Middle East & Africa, SWOT Analysis
14.6.2 Middle-East And Africa Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.6.3 South Africa
14.6.3.1 South Africa Market Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.6.4 United Arab Emirates
14.6.4.1 United Arab Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.6.5 Saudi Arabia
14.6.5.1 Saudi Arabia Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
14.6.6 Kuwait
14.6.6.1 Kuwait Cancer Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 15 Cancer Diagnostics Market: Competitive Landscape

15.1 Public Companies
15.1.1 Company Market Position Analysis
15.1.2 Competitive Dashboard Analysis
15.1.3 Strategic Framework
15.2 Private Companies
15.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
15.2.2 Regional Network Map
15.3 Company Profiles
15.3.1 F. Hoffmann-La Roche Ltd.
15.3.1.1 Company Overview
15.3.1.2 Financial Performance
15.3.1.3 Product Benchmarking
15.3.1.4 Strategic Initiatives
15.3.2 GE Healthcare
15.3.2.1 Company Overview
15.3.2.2 Financial Performance
15.3.2.3 Product Benchmarking
15.3.2.4 Strategic Initiatives
15.3.3 Abbott
15.3.3.1 Company Overview
15.3.3.2 Financial Performance
15.3.3.3 Product Benchmarking
15.3.3.4 Strategic Initiatives
15.3.3 Illumina, Inc.
15.3.3.1 Company Overview
15.3.3.2 Financial Performance
15.3.3.3 Product Benchmarking
15.3.3.4 Strategic Initiatives
15.3.4 Qiagen N.V.
15.3.4.1 Company Overview
15.3.4.2 Financial Performance
15.3.4.3 Product Benchmarking
15.3.4.4 Strategic Initiatives
15.3.5 BD
15.3.5.1 Company Overview
15.3.5.2 Financial Performance
15.3.5.3 Product Benchmarking
15.3.5.4 Strategic Initiatives
15.3.6 Siemens Healthcare GmbH
15.3.6.1 Company Overview
15.3.6.2 Financial Performance
15.3.6.3 Product Benchmarking
15.3.6.4 Strategic Initiatives
15.3.7 Thermo Fisher Scientific, Inc.
15.3.7.1 Company Overview
15.3.7.2 Financial Performance
15.3.7.3 Product Benchmarking
15.3.7.4 Strategic Initiatives
15.3.8 Hologic, Inc.
15.3.8.1 Company Overview
15.3.8.2 Financial Performance
15.3.8.3 Product Benchmarking
15.3.8.4 Strategic Initiatives
15.3.9 Koninklijke Philips N.V. (Philips)
15.3.9.1 Company Overview
15.3.9.2 Financial Performance
15.3.9.3 Product Benchmarking
15.3.9.4 Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.